Literature DB >> 19869735

ACCUMULATION OF ANTIBODIES IN THE CENTRAL NERVOUS SYSTEM.

J Freund1.   

Abstract

1. Antibodies can be extracted from the brain and spinal cord of rabbits actively or passively immunized with typhoid bacilli. 2. The titers of the antibodies in the extracts of brain and cord depend upon the titer of the blood serum. In actively immunized rabbits the following numerical relationships exist between the titers of the serum and of these organ extracts: The ratio of the titer of the serum is to the titers of extract of brain and of the spinal cord about as 100 is to 0.8; the titer of the serum is to the titer of the cerebrospinal fluid as 100 is to 0.3. In passively immunized rabbits the titer of the serum is to the titer of brain and spinal-cord extract as 100 is to 0.7. 3. The antibodies recovered from the brain are not due to the presence of blood in it for perfusion of the brain does not reduce its antibody content appreciably. 4. Antibodies penetrate into the spinal fluid from the blood even in the absence of inflammation of the meninges. When the penetration is completed the following numerical relationship exists between the titer of the serum and that of the cerebrospinal fluid: 100 to 0.25. 5. The penetration into the cerebrospinal fluid of antibodies injected intravenously proceeds at a slow rate, being completed only several hours after the immune serum has been injected. The penetration of antibodies into the tissue of the brain occurs at a very rapid rate. It is completed within 15 minutes. 6. It is very unlikely that when the immune serum is injected intravenously the antibodies reach the brain tissue by way of the cerebrospinal fluid, for (1) the antibody titer of the cerebrospinal fluid is lower than that of the brain extract, and (2) antibodies penetrate faster into the tissue of the brain than into the cerebrospinal fluid.

Entities:  

Year:  1930        PMID: 19869735      PMCID: PMC2131858          DOI: 10.1084/jem.51.6.889

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  6 in total

1.  STUDIES ON AGGLUTINATION WITH THE AID OF THE CENTRIFUGE. THE INFLUENCE OF TEMPERATURE ON ABSORPTION AND FLOCCULATION.

Authors:  F L Gates
Journal:  J Exp Med       Date:  1922-01-01       Impact factor: 14.307

2.  THE PASSAGE OF MENINGOCOCCIC AGGLUTININS FROM THE BLOOD TO THE SPINAL FLUID OF THE MONKEY.

Authors:  H L Amoss; F Eberson
Journal:  J Exp Med       Date:  1919-06-01       Impact factor: 14.307

3.  PHYSIOLOGICAL STIMULATION OF THE CHOROID PLEXUS AND EXPERIMENTAL POLIOMYELITIS.

Authors:  S Flexner; H L Amoss; F Eberson
Journal:  J Exp Med       Date:  1918-06-01       Impact factor: 14.307

4.  A CONTRIBUTION TO THE PATHOLOGY OF EPIDEMIC POLIOMYELITIS.

Authors:  S Flexner; P F Clark; H L Amoss
Journal:  J Exp Med       Date:  1914-02-01       Impact factor: 14.307

5.  THE RELATION OF THE MENINGES AND CHOROID PLEXUS TO POLIOMYELITIC INFECTION.

Authors:  S Flexner; H L Amoss
Journal:  J Exp Med       Date:  1917-04-01       Impact factor: 14.307

6.  THE PATHOLOGIC EFFECTS OF STREPTOCOCCI FROM CASES OF POLIOMYELITIS AND OTHER SOURCES.

Authors:  C G Bull
Journal:  J Exp Med       Date:  1917-04-01       Impact factor: 14.307

  6 in total
  13 in total

1.  The pathogenesis of infection with a virulent (CG 179) and an avirulent (B) strain of Newcastle disease virus in the chicken. II. Development of antibody.

Authors:  D T KARZON; F B BANG
Journal:  J Exp Med       Date:  1951-03       Impact factor: 14.307

Review 2.  Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors.

Authors:  Vidyalakshmi Chandramohan; Duane A Mitchell; Laura A Johnson; John H Sampson; Darell D Bigner
Journal:  Future Oncol       Date:  2013-07       Impact factor: 3.404

3.  INDUCED RESISTANCE OF THE CENTRAL NERVOUS SYSTEM TO EXPERIMENTAL INFECTION WITH EQUINE ENCEPHALOMYELITIS VIRUS : I. NEUTRALIZING ANTIBODY IN THE CENTRAL NERVOUS SYSTEM IN RELATION TO CEREBRAL RESISTANCE.

Authors:  I M Morgan; R W Schlesinger; P K Olitsky
Journal:  J Exp Med       Date:  1942-10-01       Impact factor: 14.307

Review 4.  Immunotherapy of malignant brain tumors.

Authors:  Duane A Mitchell; Peter E Fecci; John H Sampson
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

Review 5.  EGFRvIII-targeted vaccination therapy of malignant glioma.

Authors:  Bryan D Choi; Gary E Archer; Duane A Mitchell; Amy B Heimberger; Roger E McLendon; Darell D Bigner; John H Sampson
Journal:  Brain Pathol       Date:  2009-10       Impact factor: 6.508

6.  The mechanism of active cerebral immunity to equine encephalomyelitis virus; the local antigenic booster effect of the challenge inoculum.

Authors:  R W SCHLESINGER
Journal:  J Exp Med       Date:  1949-05       Impact factor: 14.307

7.  A consideration of the pathogenesis of bacterial meningitis: review of experimental and clinical studies.

Authors:  D H HARTER; R G PETERSDORF
Journal:  Yale J Biol Med       Date:  1960-02

8.  IMMUNITY TO YELLOW FEVER ENCEPHALITIS OF MONKEYS AND MICE IMMUNIZED BY NEURAL AND EXTRANEURAL ROUTES.

Authors:  J P Fox
Journal:  J Exp Med       Date:  1943-06-01       Impact factor: 14.307

9.  THE PASSAGE OF PROTEINS FROM THE VASCULAR SYSTEM INTO JOINTS AND CERTAIN OTHER BODY CAVITIES.

Authors:  G A Bennett; M F Shaffer
Journal:  J Exp Med       Date:  1939-08-31       Impact factor: 14.307

10.  INDUCED RESISTANCE OF THE CENTRAL NERVOUS SYSTEM TO EXPERIMENTAL INFECTION WITH EQUINE ENCEPHALOMYELITIS VIRUS : III. ABORTIVE INFECTION WITH WESTERN VIRUS AND SUBSEQUENT INTERFERENCE WITH THE ACTION OF HETEROLOGOUS VIRUSES.

Authors:  R W Schlesinger; P K Olitsky; I M Morgan
Journal:  J Exp Med       Date:  1944-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.